Harrow (HROW) Retained Earnings (2010 - 2026)
Harrow (HROW) posted quarterly Retained Earnings of $212.8 million for Q1 2026, up 225.79% year-over-year from $65.3 million in Q1 2025, and up 1.85% quarter-over-quarter from $208.9 million in Q4 2025.
Harrow (HROW) Retained Earnings (2010 - 2026) Analysis & Trends
Harrow's Retained Earnings history runs 17 years deep, the most recent figure standing at $212.8 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 225.79% year-over-year to $212.8 million; the TTM figure through Mar 2026 stood at $212.8 million (up 225.79% YoY), while the FY2025 annual figure was $208.9 million, down 5.46% from the prior year.
- Retained Earnings for Q1 2026 stood at $212.8 million, up from $208.9 million in the prior quarter.
- The five-year high for Retained Earnings was $221.0 million in Q4 2024, with the low at -$169.2 million in Q1 2025.
- The 5-year median for Retained Earnings is $142.7 million (2023), against an average of $64.9 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings surged 281.35% in 2023, then slumped 206.87% in 2024.
- Harrow's Retained Earnings stood at -$109.5 million in 2022, then fell by 22.29% to -$133.9 million in 2023, then jumped by 265.05% to $221.0 million in 2024, then retreated by 5.46% to $208.9 million in 2025, then advanced by 1.85% to $212.8 million in 2026.
- Business Quant data shows HROW's Retained Earnings at $212.8 million in Q1 2026, $208.9 million in Q4 2025, and $210.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | 216.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 216.56 Mn |
| Mar 31, 2026 | 212.80 Mn |
| Dec 31, 2025 | 208.93 Mn |
| Sep 30, 2025 | 210.13 Mn |
| Jun 30, 2025 | 213.79 Mn |
| Mar 31, 2025 | -169.17 Mn |
| Dec 31, 2024 | 221.00 Mn |
| Sep 30, 2024 | 216.10 Mn |
| Jun 30, 2024 | 212.44 Mn |
| Mar 31, 2024 | -147.47 Mn |
| Dec 31, 2023 | -133.90 Mn |
| Sep 30, 2023 | 200.48 Mn |
| Jun 30, 2023 | 142.74 Mn |
| Mar 31, 2023 | 137.99 Mn |
| Dec 31, 2022 | -109.49 Mn |
| Sep 30, 2022 | -110.55 Mn |
| Jun 30, 2022 | -104.08 Mn |
| Mar 31, 2022 | -97.85 Mn |
| Dec 31, 2021 | -95.41 Mn |
| Sep 30, 2021 | -87.99 Mn |